Graham G. Walmsley
SEC CIK 1777517 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | Dir | 1.41M | $6.87M | $44.36M | 7 | 2023-09-12 | 2024-12-17 |
Most active insiders at OLMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CLARK IAN T | Dir | — | $7.87M |
| 2 | Zojwalla Naseem | Chief Medical Off | — | $7.53M |
| 3 | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | — | $4.66M |
| 4 | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | — | $2.98M |
| 5 | Mitchell Shawnte | CLO | — | $951.5K |
| 6 | Harmon Cyrus | Dir | — | $743.8K |
| 7 | Austin Sasha Lu | VP of Fin, Ctrl | — | — |
| 8 | Bohen Sean | Pres, CEO, Dir | — | — |
| 9 | RAPPAPORT ANDREW | Dir | — | — |
Graham G. Walmsley made no open-market trades at OLMA in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2024-12-18 | 2024-12-13 | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Dir | S - Sale | $6.75 | -700.8K | 0 | -100% | -$4.73M |
| AI | 2024-12-18 | 2024-12-13 | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Dir | P - Purchase | $6.75 | +700.8K | 700.8K | New | +$4.73M |
| I | 2024-12-17 | 2024-12-17 | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Dir | P - Purchase | $6.75 | -700.8K | 1.41M | -33% | -$4.73M |
| I | 2024-12-17 | 2024-12-17 | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Dir | S - Sale | $6.75 | -700.8K | 0 | -100% | -$4.73M |
| MAI | 2024-11-26 | 2024-06-04 | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Dir | S - Sale | $14.85 | -1.18M | 700.8K | -63% | -$17.45M |
| MI | 2024-06-06 | 2024-06-04 | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Dir | S - Sale | $14.85 | -1.18M | 700.8K | -63% | -$17.45M |
| MI | 2023-12-18 | 2023-09-12+ | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Dir | P - Purchase | $10.74 | +640.0K | 1.67M | +62% | +$6.87M |
Purchase Sale Sale after option exercise All abbreviations